Literature DB >> 12359155

Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy.

Adrian M Isaacs1, Alexander Jeans, Peter L Oliver, Lucie Vizor, Steve D M Brown, A Jackie Hunter, Kay E Davies.   

Abstract

We have identified and characterized a new peripheral myelin protein 22 (Pmp22) mouse mutant. The mutation results in a serine to threonine amino acid substitution at residue 72, which is a hot spot for mutation in human PMP22, leading to the peripheral neuropathy Dejerine-Sottas syndrome. We have previously described two other Pmp22 mutants, providing an allelic series for gene function analysis. Pmp22 mutations generally lead to abnormal intracellular trafficking of Pmp22, and we show that each mutant protein in the allelic series has a unique pattern of intracellular localization in transfected cell lines. The mutant protein from the less severely affected mutants occurs in large aggregates, while the mutant protein from the most severely affected mutant occurs in a diffuse perinuclear pattern that largely colocalizes with wild-type protein. This suggests that large Pmp22 aggregates may be protective in this form of peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359155     DOI: 10.1006/mcne.2002.1158

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  10 in total

Review 1.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

3.  Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease.

Authors:  Irina Madorsky; Katherine Opalach; Amanda Waber; Jonathan D Verrier; Chelsea Solmo; Thomas Foster; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2009-04       Impact factor: 5.996

Review 4.  Myelin under stress.

Authors:  Maurizio D'Antonio; M Laura Feltri; Lawrence Wrabetz
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

5.  Ion mobility-mass spectrometry reveals the role of peripheral myelin protein dimers in peripheral neuropathy.

Authors:  Sarah M Fantin; Kristine F Parson; Pramod Yadav; Brock Juliano; Geoffrey C Li; Charles R Sanders; Melanie D Ohi; Brandon T Ruotolo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

Review 6.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

Review 7.  New insights into behaviour using mouse ENU mutagenesis.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2012-08-13       Impact factor: 6.150

8.  Inducible HSP70 is critical in preventing the aggregation and enhancing the processing of PMP22.

Authors:  Vinita G Chittoor-Vinod; Sooyeon Lee; Sarah M Judge; Lucia Notterpek
Journal:  ASN Neuro       Date:  2015-02-18       Impact factor: 4.146

Review 9.  Membrane trafficking in neuronal maintenance and degeneration.

Authors:  Dong Wang; Chih-Chiang Chan; Smita Cherry; P Robin Hiesinger
Journal:  Cell Mol Life Sci       Date:  2012-11-08       Impact factor: 9.261

Review 10.  Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease.

Authors:  Peter L Oliver; Emmanuelle Bitoun; Kay E Davies
Journal:  Mamm Genome       Date:  2007-05-21       Impact factor: 2.957

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.